H.B. Fuller Company research snapshot
FUL AI stock analysis reads H.B. Fuller as a 138-year-old industrial adhesives company with strong positions in hygiene, engineering, and construction adhesives. Q2 2026 results showed revenue of $950M (+5.8% YoY) and net income of $67.8M (+62.1% YoY), beating estimates. However, the stock dropped 8% on July 10, 2026, after the company announced a ~$715M (GBP 715M) acquisition of Advanced Medical Solutions, triggering shareholder opposition from Ancora. The company carries $2.07B in total debt against $3.01B market cap, and the AMS deal adds further leverage. At the July 10 close of $55.91, market capitalization was about $3.01B, and the forward P/E of 13x reflects concerns about integration risk, debt load, and cyclical end-market exposure.
Current price
$55.91
Market cap
$3.01 billion
AI score
52 / 100
Rating
Industrial adhesives manufacturer, high leverage, acquisition risk
Trend status
Downtrend (-8% on AMS acquisition announcement), below 50-day MA, near lower end of 52-week range
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | H.B. Fuller is a 138-year-old formulator and manufacturer of industrial adhesives, sealants, coatings, and specialty chemicals. Three segments: Hygiene/Health/Consumable Adhesives (~45% of revenue, packaging and nonwoven/hygiene), Engineering Adhesives (~30%, durable assembly and electronics), and Building Adhesive Solutions (~25%, roofing and construction). Revenue is recurring from large CPG, packaging, and construction customers. | High |
| Moat | The moat is moderate: long-standing customer relationships, formulation expertise, regulatory compliance, and global manufacturing footprint. Switching costs are real once an adhesive formulation is qualified in a customers production line. No network effects or patent wall. Competitors include Henkel, Sika, RPM International, and 3M. | Medium |
| Management | CEO Celeste Beeks Mastin (since 2023) came from the board with prior experience at Pentair and Donaldson. The AMS acquisition decision suggests an aggressive growth strategy that has drawn shareholder opposition from Ancora. Capital allocation track record is mixed: steady dividend growth, periodic share repurchases, and serial acquisitions that add debt. | Medium |
| Financial trend | Q2 2026 revenue grew 5.8% YoY to $950.27M, net income grew 62.1% YoY to $67.81M. TTM revenue ~$3.48B, TTM net income ~$160M (Yahoo) to $186M (Motley Fool, adjusted). Gross margin 33.9%, operating margin 11.7%, net margin 4.6-5.3%. ROE 8.8%. Debt/equity 108% is high for specialty chemicals. | High |
| Valuation | At 19.4x TTM P/E, 1.70x P/B, 1.0x P/S, and 14.6x P/FCF, FUL is reasonably valued on a standalone basis. Forward P/E of 13x is cheap but reflects the AMS acquisition overhang and leverage. EV/EBITDA ~10x. Before the AMS announcement, FUL traded near $64-65, and the post-drop price of $56 suggests the market is pricing in significant acquisition risk. | Medium |
| Technical trend | FUL dropped 8% on July 10 to close at $55.91 after the AMS acquisition news. The stock is now near the lower end of its 52-week range ($48.71 - $68.63) and likely below its 50-day and 200-day moving averages. Prior to the drop, FUL was in a sideways trend around $64-65. Key support at $53 and then $48.71 (52-week low). Resistance at $60 (round number) and $64.60 (pre-drop close). | Medium |
| Risk level | Elevated. Key risks: total debt of $2.07B (108% debt/equity), the AMS acquisition (~$715M planned) will add significant leverage, shareholder opposition (Ancora) creates governance uncertainty, thin net margins (~5%) leave little room for error, cyclical exposure to construction, packaging, and durable goods, and raw material cost volatility (petrochemical-based inputs). | Medium |
| AI confidence | High for descriptive analysis of historical financials. Lower for forward returns because the AMS acquisition will reshape the business profile, balance sheet, and earnings trajectory in ways that are not yet fully specified. | High data confidence |
| Investment certainty | Medium-low. The adhesives business is durable with real customer switching costs, but the high debt load and AMS acquisition create a risk/reward setup where downside scenarios are more probable until the integration plan is detailed and shareholder concerns are addressed. | Medium-low |
FUL AI stock forecast
The FUL AI stock forecast should be read as scenario math, not a price promise. Using a July 10, 2026 close near $55.91, TTM EPS of $2.89, and a three-year framework, the tested range spans a bearish area near $32, a base area near $51, and a bullish area near $88. These outputs depend on EPS growth, AMS acquisition integration, debt reduction progress, end-market demand, and the terminal earnings multiple.
$78 to $92
More likely if the AMS acquisition is completed smoothly with $55M+ in announced synergies, debt is reduced faster than expected, margins expand past 12% operating margin, and the market assigns a 18-20x multiple to a higher-growth, higher-margin combined entity.
$46 to $56
More likely if FUL manages moderate 6-8% EPS compounding, the AMS deal closes with some dilution and integration friction, debt remains elevated at 3-4x EBITDA, and the market holds the P/E near 12-14x reflecting the higher leverage profile.
$28 to $36
More likely if the AMS acquisition faces regulatory delays, shareholder opposition blocks or forces a renegotiation, integration costs erode margins, a recession reduces packaging and construction demand, or the P/E multiple contracts toward 8-10x due to leverage concerns.
FUL AI technical analysis
FUL technical analysis as of July 10, 2026 shows a sharp break downward following the AMS acquisition announcement. The stock gapped down from the prior close of $64.60 to open near $61.42 and closed at $55.91, an 8% single-day loss. The stock is now trading near the lower end of its 52-week range ($48.71 - $68.63). The 50-day SMA was likely near $60-62 and the 200-day SMA near $58-60 before the drop. Beta near 1.0 suggests market-level volatility. Data cutoff: July 10, 2026 close.
| Level | Value | Why it matters |
|---|---|---|
| Resistance (pre-drop close) | $64.60 | Primary resistance. The price before the AMS announcement. Recovery to this level would signal the market has accepted the acquisition terms. |
| Resistance (round number) | $60 | Psychological resistance. Many traders will use this level as a short-term target in any relief rally. |
| Support (psychological) | $53 | Near-term support. A level where buyers may step in if the market decides the AMS deal panic was overdone. |
| Support (52-week low) | $48.71 | Major support from the 52-week low. A break below with volume would indicate the market is pricing in a materially worse outcome for the AMS acquisition. |
| 50-day SMA (estimated) | $61 | The 50-day SMA was trending near $61-62 before the gap down. Price is now well below it, confirming short-term bearish momentum. |
| 200-day SMA (estimated) | $59 | The 200-day SMA was near $58-60. Price below both moving averages signals a bearish technical posture. |
| Beta (5Y) | 0.96 | Near-market beta. FUL tends to move roughly in line with the S&P 500 over longer periods. |
FUL AI trading strategy
The FUL AI trading strategy framework below is provided for informational reference, not personalized advice. H.B. Fullers high debt profile, AMS acquisition uncertainty, and cyclical end-market exposure create distinct patterns that traders may incorporate into systematic approaches. Use Pineify stock screener and Pine Script builder to design and backtest your own strategy conditions.
The AMS acquisition creates a classic event-driven opportunity. Monitor for: (1) shareholder vote announcement, (2) regulatory clearance, (3) updated synergy targets. A long entry near $53-55 support with a stop below the 52-week low ($48.71) could capture a recovery if the deal terms are finalized favorably.
Risk per trade: 1-2% of capital. Wide stop at $48 or $47. Invalidation: the deal collapses or regulatory opposition emerges. Consider reducing position size given the binary event risk.
If the AMS acquisition is abandoned or renegotiated at better terms, FUL could gap back toward $60-65. Entry on confirmation of deal restructuring with volume confirmation. Target $64.60 (pre-drop close) as the first target.
Risk per trade: 2-3% of capital if the catalyst is confirmed. Stop at $52 (below support). Faster traders may also short at $60-61 resistance if the recovery stalls.
Hold the stock for the 1.70% dividend yield with quarterly payments (next ex-date: expected late July or early August 2026). Covered calls at the $60 or $65 strike can generate 1-2% additional monthly premium. Monitor payout ratio of ~28% for sustainability.
Portfolio allocation: 3-5% for income positions. If the AMS acquisition drains free cash flow, the dividend growth rate may slow. Watch for management commentary on dividend policy during the acquisition process.
Investment research summary
H.B. Fuller sells adhesives that hold together packaging, diapers, electronics, cars, buildings, and aircraft. Customers (packaging companies, CPG manufacturers, construction firms, automotive suppliers) pay for formula reliability, production-line compatibility, and global supply assurance. The business is a specialty chemical formulator with recurring revenue from consumable adhesives used in mass production processes.
Moderate moat from customer relationships (once an adhesive formula is qualified on a clients production line, switching costs are high), formulation expertise, regulatory certifications (food-grade, medical-grade adhesives), and a global manufacturing footprint. Competitors include Henkel (stronger in consumer adhesives), Sika (stronger in construction), RPM International (stronger in specialty coatings), and 3M (broader industrial portfolio). No network effects or strong technology moat.
Worst case: the AMS acquisition burdens the balance sheet with excessive debt while integration fails to deliver promised synergies. A recession reduces packaging and construction demand, compressing margins to breakeven. Debt covenants are breached, forcing a distressed equity issuance. Another risk: shareholder opposition delays or kills the deal, but not before significant advisory fees and management distraction have been incurred.
CEO Celeste Beeks Mastin took over in 2023, succeeding the long-tenured Jim Owens. The AMS acquisition is her defining strategic move to date. Capital allocation has emphasized growth through M&A (Royal Adhesives, Beardow Adams, GSSI, now AMS), maintaining the dividend (paid since 1913), and moderate share repurchases. Insider ownership is modest. The Ancora shareholder opposition highlights governance tension around the deal strategy.
The global adhesives and sealants market is growing 4-6% annually, driven by packaging automation, lightweighting in automotive and aerospace, construction growth in emerging markets, and hygiene product demand. The shift toward sustainable and bio-based adhesives is creating both R&D requirements and market opportunities. The industry is mature, not subject to technological disruption, but is directly tied to industrial production and construction cycles.
At 19.4x TTM P/E and 1.0x P/S, FUL is reasonably priced on a standalone basis. Forward P/E of 13x reflects the AMS acquisition overhang. The three-scenario range ($32 bearish to $88 bullish) is wide. For a value-oriented investor, the key question is whether the AMS deal creates value or destroys it. At $56, the market is implying significant skepticism. A margin of safety would require conviction that FUL can deleverage quickly and integrate AMS successfully.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price | $55.91 | Motley Fool / Yahoo Finance | July 10, 2026 |
| Market cap | $3.01B | Motley Fool (verified via price x shares) | July 10, 2026 |
| Enterprise value | $4.97B (estimated) | Calculated: market cap + debt - cash | July 10, 2026 |
| Revenue (TTM) | $3.48B (consensus) | Yahoo Finance / Motley Fool | July 10, 2026 |
| Net income (TTM) | ~$160M (GAAP) / ~$186M (adjusted) | Yahoo Finance / Motley Fool (7.5% source discrepancy noted) | July 10, 2026 |
| EPS (TTM) | $2.89 (GAAP) | Yahoo Finance | July 10, 2026 |
| P/E ratio (TTM) | 19.35 | Verified via price / EPS | July 10, 2026 |
| Forward P/E | ~13.4x | Yahoo Finance | July 10, 2026 |
| P/S ratio (TTM) | 1.03 | Yahoo Finance | July 10, 2026 |
| P/B ratio | 1.70 | Yahoo Finance | July 10, 2026 |
| EV/EBITDA (TTM) | ~10.2x | Yahoo Finance | July 10, 2026 |
| Gross margin (TTM) | 32.5% | Motley Fool | July 10, 2026 |
| Operating margin (TTM) | 11.7% | Motley Fool | July 10, 2026 |
| Net margin (TTM) | 4.6-5.3% | Yahoo Finance / Motley Fool | July 10, 2026 |
| ROE (TTM) | 8.8% | Verified via EPS / BVPS | July 10, 2026 |
| Free cash flow (TTM) | $140M - $205M (varies by definition) | Motley Fool / Yahoo Finance | July 10, 2026 |
| Total debt | $2.07B | Motley Fool | July 10, 2026 |
| Cash & equivalents | $114M | Motley Fool | July 10, 2026 |
| Dividend yield | 1.70% | Motley Fool / Yahoo Finance | July 10, 2026 |
| Beta (5Y) | 0.96 | Yahoo Finance | July 10, 2026 |
| 52-week range | $48.71 - $68.63 | Yahoo Finance | July 10, 2026 |
| Shares outstanding | 53.79M | Motley Fool (verified via market cap / price) | July 10, 2026 |
This FUL AI stock analysis page is an informational research tool, not investment advice. Forecast scenarios are based on available data as of July 12, 2026 and may be wrong. Past performance does not guarantee future results. All investment decisions are your own responsibility. Consult a qualified financial advisor before making trading or investment decisions. Data sources include Yahoo Finance, Motley Fool, and H.B. Fuller SEC filings. Net income data shows a 7.5% discrepancy between Yahoo Finance ($159.76M) and Motley Fool ($185.74M), likely due to GAAP vs adjusted reporting, and should be investigated further by any investor relying on this data.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
